Immune cells in the bone marrow microenvironment of AML patients are key in distinguishing a response to immunotherapy.

This site uses cookies to enhance your user experience. By continuing to use this site you are agreeing to our COOKIE POLICY.

If Maggie O'Neil can't find a bone marrow match among family members, she'll have to turn to an anonymous donor through the ...

In recent days, the Armenian Bone Marrow Donor Registry held two donor recruitment drives in the Los Angeles area, to find ...

Melvin Mann, diagnosed with chronic myeloid leukemia in 1994, participated in a clinical trial for Imatinib that extended his ...

To do this, they examined cells from the bone marrow of 25 patients with relapsed leukemia who had been treated with stem ...

Our Lady of the Lake Cancer Institute is celebrating after successfully completing a bone marrow transplant so rare it has ...

NEW ORLEANS (WVUE/Gray News) - A 2-year-old boy who was diagnosed with a rare and aggressive cancer has received a ...

Discover how groundbreaking research on unique immune cells and advanced AI tools offers renewed hope for improving cancer ...

Columbia Engineering and Irving Institute researchers unveil a significant finding in cancer immunotherapy, uncovering unique ...

Researchers have identified key factors that determine the success of leukemia cell therapies, including DLI, in achieving ...